EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   1.8.98.2 | Breast Neoplasms |
22964583 |
Genetic polymorphisms and protein expression of NRF2 and sulfiredoxin predict survival outcomes in breast cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
1 |
| 1.8.98.2 | Cerebrovascular Disorders |
27226772 |
Genetic Polymorphisms of Transcription Factor NRF2 and of its Host Gene Sulfiredoxin (SRXN1) are Associated with Cerebrovascular Disease in a Finnish Cohort, the TAMRISK Study. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
3
0 |
| 1.8.98.2 | Hypertension |
27226772 |
Genetic Polymorphisms of Transcription Factor NRF2 and of its Host Gene Sulfiredoxin (SRXN1) are Associated with Cerebrovascular Disease in a Finnish Cohort, the TAMRISK Study. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
3
0 |
| 1.8.98.2 | Neoplasms |
21595034 |
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 1.8.98.2 | Prostatic Neoplasms |
26637857 |
Increased Peroxiredoxin 6 Expression Predicts Biochemical Recurrence in Prostate Cancer Patients After Radical Prostatectomy. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
1 |
| 1.8.98.2 | Stomach Neoplasms |
30863778 |
Increased Sulfiredoxin Expression in Gastric Cancer Cells May Be a Molecular Target of the Anticancer Component Diallyl Trisulfide. |
causal interaction
unassigned |
4
0 |
| 1.8.98.2 | Carcinogenesis |
23393226 |
Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis. |
causal interaction
ongoing research
unassigned |
1
3
0 |
| 1.8.98.2 | Breast Neoplasms |
21742584 |
Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 1.8.98.2 | Leukemia, Myeloid, Acute |
21742584 |
Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 1.8.98.2 | Brain Ischemia |
28552673 |
Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
